«Pharmaceutical products / Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products»
HS code: 3002
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2016 | <hidden> |
2017 | <hidden> |
Total: | <hidden> |
№ | Country | ∑ (2016-2017) | Ratio |
---|---|---|---|
1 | Germany | <hidden> | <hidden>% |
2 | United States | <hidden> | <hidden>% |
3 | Belgium | <hidden> | <hidden>% |
4 | Canada | <hidden> | <hidden>% |
5 | Armenia | <hidden> | <hidden>% |
6 | China | <hidden> | <hidden>% |
7 | France | <hidden> | <hidden>% |
8 | United Kingdom | <hidden> | <hidden>% |
9 | Spain | <hidden> | <hidden>% |
10 | Poland | <hidden> | <hidden>% |
11 | Finland | <hidden> | <hidden>% |
12 | Bulgaria | <hidden> | <hidden>% |
13 | Belarus | <hidden> | <hidden>% |
14 | Ireland | <hidden> | <hidden>% |
15 | Japan | <hidden> | <hidden>% |
16 | India | <hidden> | <hidden>% |
The total for all countries: | <hidden> | 100% |